Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Apr 27, 2024; 16(4): 1149-1154
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.1149
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.1149
Variables | Control group | Experiment group |
Sample size | 60 | 60 |
Male (%) | 46 | 53 |
Age (yr), mean ± SD | 44.7 ± 7.7 | 48.7 ± 7.7 |
Duration of illness (yr), mean ± SD | 7.3 ± 2.3 | 8.1 ± 3.2 |
Group | Sample size | Initial stage | One month after | ||
TLR4 (%) | NF-κB (ng/L) | TLR4 (%) | NF-κB (ng/L) | ||
Experiment group | 60 | 38.35 ± 7.5 | 164 ± 12.2 | 21.69 ± 2.79 | 98.24 ± 35.64 |
Control group | 60 | 40.11 ± 15.3 | 162.73 ± 45.23 | 39.37 ± 4.35 | 163.33 ± 65.45 |
Group | Sample size | Initial stage | One month after | ||
IL-6 (ng/L) | IL-17 (ng/L) | IL-6 (ng/L) | IL-17 (ng/L) | ||
Experiment group | 60 | 19.78 ± 12.23 | 13.56 ± 14.23 | 8.01 ± 1.02 | 9.08 ± 2.02 |
Control group | 60 | 21.89 ± 3.24 | 11.36 ± 9.00 | 20.15 ± 2.40 | 12.25 ± 2.80 |
- Citation: Han L, Tang K, Fang XL, Xu JX, Mao XY, Li M. Kuicolong-yu enema decoction retains traditional Chinese medicine enema attenuates inflammatory response ulcerative colitis through TLR4/NF-κB signaling pathway. World J Gastrointest Surg 2024; 16(4): 1149-1154
- URL: https://www.wjgnet.com/1948-9366/full/v16/i4/1149.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i4.1149